Behavior Change and Health-Related Interventions for Heterosexual Risk Reduction Among Drug Users

References

• Aceijas C., Stimson G. V., Hickman M., Rhodes T., on behalf of the United Nations reference group on HIV AIDS prevention and care among IDU in developing and transitional countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18: 2295–2303
   PubMed Web of Science ®Google Scholar
• Amico K. R., Harman J. J., Johnson B. T. Efficacy of antiretroviral therapy adherence interventions. Journal of Acquired Immune Deficiency Syndrome (in press) 2006
   Google Scholar
• Andersen R., Bozzette S., Shaprio M., St. Clair, Morton S., Crystal S. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Services Research 2000; 35: 389–416
   PubMed Web of Science ®Google Scholar
• Aronowitz T., Rennells R. E., Todd E. Heterosexual behaviors in early adolescent African American girls: the role of mother-daughter relationships. Journal of Family Nursing 2005; 11: 122–139
   PubMed Web of Science ®Google Scholar
• Bachmann L. H., Lewis I., Allen R., Schwebke J. R., Leviton L. C., Siegal H. A. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham susbtance abuse treatment facility. American Journal of Public Health 2000; 90: 1615–1618
   PubMed Web of Science ®Google Scholar
• Bandura A. Social cognitive theory and excercise of control over HIV infection. In: Peterson. Preventing AIDS: Theory and Practice of Behavioral Interventions, J. & R. DiClemente. Plenum Press, New York 1993
   Google Scholar
• Bellg A. J.et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychology. Plenum Press, New York 2004; 23: 443–451
   Google Scholar
• Beyrer C., Razak M. H., Jittiwutikran J., Suriyanon V., Vongchak T., Srirak N. Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking susbstance abusers. International Journal of STD & AIDS 2004; 15: 697–704
   PubMed Web of Science ®Google Scholar
• Blankenship K. M., Bray S. I., Merson M. H. Structural interventions in public health. AIDS 2000; 14: S11–S21
   PubMed Web of Science ®Google Scholar
• Bogart L. M., Catz S. L., Kelly J. A., Benotsch E. G. Factors influencing physicians’ judgements of adherence and treatment decisions for patients with HIV disease. Medical Decision Making 2000; 21: 28–36
   Web of Science ®Google Scholar
• Booth R., Watters J. How effective are risk reduction intervnetions targeting injection drug users?. AIDS 1994; 8: 1515–1524
   PubMed Web of Science ®Google Scholar
• Bouhnik A. D., Moatti J. P., Vlahov D., Gallais H., Dellamonica P., Obadia Y. Highly active antiretroviral treatment does not increase sexual risk behavior among French HIV infected injecting drug users. Journal of Epidemiology and Community Health 2002; 56: 349–353
   PubMed Web of Science ®Google Scholar
• Broadhead R. S., Heckathorn D. D., Altice F. L., Hulst Y., van Carbone M., Friedland G. H. Increasing drug users’ adherence to HIV treatment: Results of a peer-driven intervention feasibility study. Social Science and Medicine 2002; 55: 235–246
   PubMed Web of Science ®Google Scholar
• Handbook on Risk of AIDS: Injection Drug Users and Their Sexual Partners, B. S. Brown, G. M. Beschner. Greenwood Press, Westport, CT 1993
   Google Scholar
• Brown N. L., Luna V., Ramirez M. H., Vail K. A., Williams C. A. Developing an effective intervnetion for IDU women: a harm reduction approach to collaboration. AIDS Education and Prevention 2005; 17: 317–333
   PubMed Web of Science ®Google Scholar
• Campbell J. V., Hagan H., Latka M. H., Garfein R. S., Golub E. T., Coady M. H. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug and Alcohol Dependence 2005
   PubMed Web of Science ®Google Scholar
• Celentano D. D., Vlahov D., Cohn S., Shadle V. M., Obasanjo O., Moore R. D. Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association 1998; 280: 544–546
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic—United States 2003. Morbidity and Mortality Weekly Report 2003; 52: 329–332
   PubMedGoogle Scholar
• Chakraborty H., Helms R. W., Sen P. K., Cohen M. S. Estimating correlation by using a general linear mixed model: evaluation of the relationship between the concentration of HIV–RNA in blood and semen. Statistics in Medicine 2003; 15: 9–1457
   Google Scholar
• Chakraborty H., Sen P. K., Helms R. W., Vernazza P. L., Fiscus C. A., Eron J. J. Viral burden in genital secretions determines male-to-female sexual trnasmission of HIV-1: a probabilistic empiric model. AIDS 2001; 15: 641–643
   PubMed Web of Science ®Google Scholar
• Chiao C., Morisky D., Rosenberg R., Malow R. The relationship between HIV STI risk and alcohol use during commercial sex episodes: results from the study of female commercial sex workers in the Philippines. Substance Abuse & Misuse 2006; 41: 00–00
   Web of Science ®Google Scholar
• Cook R. L., Clark D. B. Is there an assocation between alcohol consumption and sexually transmitted diseases? A systematic review. Sexually Transmitted Diseases 2005; 32: 156–164
   PubMed Web of Science ®Google Scholar
• Cooper H., Hedges L. V. The Handbook of Research Synthesis. Russell Sage Foundation, New York 1994
   Google Scholar
• Coyle S. L., Needle R. H., Normand J. Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Reports 1998; 113: 19–30
   PubMed Web of Science ®Google Scholar
• Crepaz N., Hart T. A., Marks G. Highly active antiretroviral therapy and sexual risk behavior. Journal of American Medical Association 2004; 292: 224–236
   PubMed Web of Science ®Google Scholar
• Cross J. E., Saunders C. M., Bartelli D. The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity 1998; 32: 165–180
   Google Scholar
• Dawson-Rose C., Shade S. B., Lum P. J., Knight K. R., Parsons J. T., Purcell D. W. Health care experiences of HIV positive injection drug users. Journal of Multicultural Nursing & Health 2005; 11: 23–30
   Google Scholar
• De Cock K. M., Marum E., Mbori-Nagacha D. A serostatus-based approach to HIV prevention and care in Africa. Lancet 2002; 362: 1847–1849
   Web of Science ®Google Scholar
• Des Jarlais D. C. Structural interventions to reduce HIV transmission among injecting drug users. AIDS 2000; 14: S41–S46
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R.et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995; 274: 1226–1231
   PubMed Web of Science ®Google Scholar
• Des Jarlais et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS 1995; 6: 611–617
   Google Scholar
• Des Jarlais D. C., Marmor M., Paone D. et al. HIV incidence among injecting drug users in New York City syringe exchange programs. Lancet, 348: 987–991
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Wenston J., Sotheran J. L., Maslansky R., Marmor M. Crack cocaine use in a cohort of methadone maintenance patients. Journal of Substance Abuse Treatment 1992; 9: 319–325
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R. Epidemiology and emerging public health perspectives. In: Lowinson. Sustance Abuse: A Comprehensive TextbookThird edition, J. H. P. Ruiz, R. B. Millman, J. G. eds & Langrod. Williams and Wilkins, Baltimore, MD 1997; 591–597
   Google Scholar
• Des Jarlais D. C., Chamberland M. E., Yancovitz S. R., Weinberg P., Friedman S. R. Heterosexual partners: a large risk group for AIDS. Lancet 1984; 2: 1347
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Friedman S. R., Novick D. M., Sotheran J. L., Thomas P., Yancovitz S. R. HIV-1infection among intravenous drug users in Manhattan New York City from 1977 through 1987. JAMA 1989; 261: 1008–1012
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Perlis T., Arasteh K., Torian L. V., Beatrice S., Milliken J. HIV incidence among injection drug users in New York City 1990 to 2002: use of serologic test alogorithm to assess expansion of HIV prevention services. American Journal of Public Health 2005; 95: 1439–1444
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Perlis T., Firedmann P., Stimson G., Poznyak V.. Issues in HIV prevention for injecting drug users (IDUs) in developing transitional countries: results from the WHO phase II drug injection study. Paper presented at the Bangkok International AIDS Conference, Bangkok, Thailand, 2004
   Google Scholar
• Desenclos J. C., Papaevangelou G., Ancelle-Park R. Knowledge of HIV serostatus and preventive behavior among European injecting drug users. AIDS 1993; 7: 1371–1377
   PubMed Web of Science ®Google Scholar
• Elwy A. R., Hart G. J., Hawkes S. Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men. Archives of Internal Medicine 2002; 162: 1818–1830
   PubMed Web of Science ®Google Scholar
• Emerson C., Brown T., Illemsky S., Jean-Jacques L., Boyles R., Simpson G. Use of social networks to identify persons with undiagnosed HIV infection—Seven U.S.cities October 2003–September 2004. Morbidity and Mortality Weekly Report 2005; 54: 601–605
   PubMedGoogle Scholar
• Farabee D., Prendergast M., Cartier J. Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs 2002; 34: 295–300
   PubMed Web of Science ®Google Scholar
• Farrell M., Gowing L., Marsden J., Ling W., Ali R. Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy 2005; 16: 67–75
   Web of Science ®Google Scholar
• Feist-Price S., Logan T. K., Leukefeld C., Moore C. L., Ebreo A. Targeting HIV prevention on African American crack and injection drug users. Substance Use & Misuse 2003; 38: 1259–1284
   PubMed Web of Science ®Google Scholar
• Fournier A. M., Carmichael C. Socioeconomic influences on the transmission of human immunodeficiency virus infection: the hidden risk. Archives of Family Medicine 1998; 7: 214–217
   PubMedGoogle Scholar
• Freeman E. E., Weiss H. A., Glynn J. R., Cross P. L., Whitworth J. A., Hayes R. J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73–83
   PubMed Web of Science ®Google Scholar
• Friedman S. R., Flom P. L., Kottiri B. J., Zenilman J., Curtis R., Neaigus A. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighborhood in New York. Addiction 2003a; 98: 159–169
   PubMed Web of Science ®Google Scholar
• Friedman S. R., Kang S. Y., Deren S., Robles R., Colon H. M., Andia J. Drug-scene roles and HIV risk among Puerto rican injection drug users in East Harlem, New York and Baymon, Puerto Rico. Journal of Psychoactive Drugs 2002; 34: 363–369
   PubMed Web of Science ®Google Scholar
• Friedman S. R., Maslow C., Bolyard M., Sandoval M., Mateu-Gelabert P., Neaigus A. Urging others to be healthy: “intravention” by injection drug users as a community prevention goal. AIDS Education and Prevention 2004; 16: 250–263
   PubMed Web of Science ®Google Scholar
• Friedman S. R., Ompad D., Maslow C. HIV prevalence social marginalization, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. American Journal of Public Health 2003b; 93: 902–906
   PubMed Web of Science ®Google Scholar
• Fullilove R. E., Green L., Fullilove M. T. The family to family program: a structural intervention with implications for the prevention of HIV AIDS and other community epidemics. AIDS 2000; 14: S63–S67
   PubMed Web of Science ®Google Scholar
• Galea S., Vlhaov D. Social determinants and the health of drug users: socioeconomic status homelessness, and incarceration. Public Health Reports 2002; 117: S135–S145
   PubMed Web of Science ®Google Scholar
• Gebrekristos H. T., Mlisana K. P., Karim Q. A. Patients’ readiness to start highly active antiretroviral treatment for HIV. British Medical Journal 2005; 331: 772–775
   PubMed Web of Science ®Google Scholar
• Gibson D. R., McCusker J., Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users. AIDS 1998; 12: 919–929
   PubMed Web of Science ®Google Scholar
• Gordon C. M., Forsyth A. D., Stall R., Cheever L. W. Prevention interventions with persons living with HIV AIDS: state of the science and future directions. AIDS Education and Prevention 2005; 17: 6–20
   PubMed Web of Science ®Google Scholar
• Gourevitch M. N., Hartel D., Schoenbaum E. E., Selwyn P. A., Davenny K., Friedland G. H. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. American Journal of Public Health 1996; 86: 1112–1115
   PubMed Web of Science ®Google Scholar
• Grassly N. C., Lowndes C. M., Rhodes T. Modeling emerging HIV epidemics: the role of injection drug use and sexual transmission in the Russian Federation, China, and India. International Journal of Drug Policy 2003; 14: 25–43
   Google Scholar
• Gray R., Wawer M., Sewankambo N. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. AIDS 1999; 13: 2113–2123
   PubMed Web of Science ®Google Scholar
• Greenberg A. E., Tappero J., Choopanya K., VanGriensven F., Martin M., Vanichseni S. CDC international HIV prevention research activities among IDUs in Thailand and Russia. Journal of Urban Health 2005; 82: iv24–iv33
   PubMed Web of Science ®Google Scholar
• Grosskurth H. M. F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 1995; 346: 530–536
   PubMed Web of Science ®Google Scholar
• Gunn R. A., Lee M. A., Callahan D. B., Gonzales P., Murray P. J., Margolis H. S. Integrating hepatitis STD and HIV services into a drug rehabilitation program. American Journal of Preventive Medicine 2005; 29: 27–33
   PubMed Web of Science ®Google Scholar
• Hamburger M. E., Moore J., Koenig L. J., Vlahov D., Schoenbaum E. E., Schuman P. Persistence of inconsistent condom use: relation to abuse history and HIV serostatus. AIDS and Behavior 2004; 8: 333–344
   PubMed Web of Science ®Google Scholar
• Hedges L., Veva J. Fixed-and random-effects models in meta-analysis. Psychological Methods 1998; 3: 486–504
   Web of Science ®Google Scholar
• Hedges L. V., Johnson W. D., Semaan S., Sogolow W. Theoretical issues in the synthesis of HIV prevention research. Journal of Acquired Immune Deficiency Syndrome 2002; 30: S8–S14
   Web of Science ®Google Scholar
• Hitchcock P., Fransen L. Preventing HIV infection: lessons from Mwanza and Rakai. Lancet 1999; 353: 513–515
   PubMed Web of Science ®Google Scholar
• Hwang L. Y., Ross M. W., Zack C., Bull L., Rickman K., Holleman M. Prevalence of sexually transmitted infections and assoicated risk factors among populations of drug users. Clinical Infectious Diseases 2000; 31: 920–926
   PubMed Web of Science ®Google Scholar
• Janssen R. S., Holtgrave D. R., Valdiserri R. O. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. American Journal of Public Health 2001; 91: 1019–1024
   PubMed Web of Science ®Google Scholar
• Jeanty Y. J., Metsch L. R., Wilkinson J. D., McCoy C. B. An investigation of the correlates and predictors of adherence to HIV medication therapy in substance abusing populations. Annual Meeting of the American Public Health Association, abstract 71243. 2003
   Google Scholar
• Johnson W. D., Semaan S., Hedges L. V., Ramirez G., Mullen P. D., Soglow E. A protocol for the analytical aspects of a systematic review of HIV prevention research. Journal of Acquired Immune Deficiency Syndrome 2002; 30: S62–S72
   Web of Science ®Google Scholar
• Kim J. C., Watts C. H. Gaining a foothold: tackling poverty, gender inequality, and HIV in Africa. British Medical Journal 2005; 331: 769–772
   PubMed Web of Science ®Google Scholar
• Knowlton A. R., Hoover D. R., Chung S. E., Celentano D. D., Vlahov D., Latkin C. A. Access to medical care and service utilization among injection drug users with HIV AIDS. Drug and Alcohol Dependence 2001; 64: 55–62
   PubMed Web of Science ®Google Scholar
• Kral A. H., Bluthenthal R. N., Lorvick J., Gee L., Bacchetti P., Edlin B. R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001; 357: 1397–1401
   PubMed Web of Science ®Google Scholar
• Kral A. H., Lorvick J., Edlin B. R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J AIDS 2000; 24: 162–167
   PubMed Web of Science ®Google Scholar
• Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention 2003; 15: 257–268
   PubMed Web of Science ®Google Scholar
• Ksobiech K., Malow R. Injection drug use, poverty and HIV among U.S. minorities: the necessity of targeted intervention approaches. Newsletter of addiction division of the American Psychological Association 2005; 12: 10–12
   Google Scholar
• Kuyper L. M., Palepu A., Kerr T., Kathy L., Miller C. L., Spittal P. M. Factors associated with sex-trade involvement among female injection drug users in a Canadian setting. Addiction Research and Theory 2005; 13: 193–199
   Web of Science ®Google Scholar
• Lally M. A., Alvarez S., Macnevin R., Cenedella C., Dispigno M., Harwell J. I. Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment. Sexually Transmitted Diseases 2002; 29: 752–755
   PubMed Web of Science ®Google Scholar
• Latka M., Ahern J., Garfien R. S., Ouellet L., Kerndt P., Morse P. Prevalence incidence and correlates of chlamydia and gonorrhea among young adult injection drug users. Journal of Substance Abuse 2001; 13: 73–88
   PubMedGoogle Scholar
• Latkin C. A., Hua W., Forman V. L. The relationship between social network characteristics and exchanging sex for drugs or money among drug users in Baltimore, M.D., U.S.A. Internat J STD AIDS 2003a; 14: 770–775
   PubMed Web of Science ®Google Scholar
• Latkin C. A., Knowlton R. A. Micro-social structural approches to HIV prevention: a social ecological perspective. AIDS Care 2005; 17: S102–S113
   Web of Science ®Google Scholar
• Latkin C. A., Mandell W., Vlahov D., Oziemkowska M., Celantano D. D. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the Safe Study. American Journal of Community Psychology 1996; 24: 341–364
   PubMed Web of Science ®Google Scholar
• Latkin C. A., Sherman S., Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychology 2003b; 22: 332–339
   PubMed Web of Science ®Google Scholar
• Latkin C. A., Williams C. T., Wang J., Curry A. D. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychology 2005; 24: 96–100
   PubMed Web of Science ®Google Scholar
• Lee D. M., Binger A., Hocking J., Fairley C. K. The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalized and regulated system in Melbourne. Sexually Transmitted Infections 2005; 81: 434–436
   PubMed Web of Science ®Google Scholar
• Liebschutz J. M., Finley E. P., Braslins P. G., Christiansen D., Horton N. J., Samet J. H. Screening for sexually transmitted infections in substance abuse treatment programs. Drug and Alcohol Dependence 2003; 70: 93–99
   PubMed Web of Science ®Google Scholar
• Logan T. K., Leukefeld C. F. D. Sexual and drug use behaviors among women crack users: implications for prevention. AIDS Education and Prevention 1998; 10: 327–340
   PubMed Web of Science ®Google Scholar
• Logan T. K., Leukefeld C. Sexual and drug use behaviors among female crack users: a multi-site sample. Drug and Alcohol Dependence 2005; 58: 237–245
   Google Scholar
• Lopez-Zetina J., Ford W., Weber M., Barna S., Woerhle T., Kerndt P. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County 1994–1996. Sexually Transmitted Infections 2000; 76: 462–469
   PubMed Web of Science ®Google Scholar
• Maclachlan E. W., Baganizi E., Bougoudogo F. The feasibility of integrated sexually transmitted infections prevalence and behavior surveys in eveloping countries. Sexually Transmitted Infections 2002; 78: 187–189
   PubMedGoogle Scholar
• Malow R. M., Rosenberg R., Devieux J. Prevention of infection with human immunodeficiency virus in adolescent substance abusers. Adolescent Substance Abuse: Research and Clinical Advances, H. Liddle, C. Rowe. Cambridge Press, Boston 2006; 284–309
   Google Scholar
• Malta M., Carneiro-da-Cunha C., Kerrigan D., Strathdee S. A., Monteiro M., Bastos F. L. Case management of human immunodeficiency virus-infected injection drug users: a case study in Rio de Janeiro, Brazil. Clinical Infectious Diseases 2003; 15(Suppl 5)S386
   Google Scholar
• Mansergh G., Purcell D. W., Stall R., McFarlane M., Semaan S., Valentine J. CDC consultation on methamphetamine use and sexual risk behavior for HIV STD infection: summary and suggestions. Public Health Reports 2006; 121: 127–132
   PubMed Web of Science ®Google Scholar
• Margolin A., Avants S. K., Warburton L. A., Hawkins K. A., Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychology 2003; 22: 223–228
   PubMed Web of Science ®Google Scholar
• Markos A. R. Alcohol and sexual behavior. International Journal of STD and AIDS 2005; 16: 123–127
   PubMed Web of Science ®Google Scholar
• Marks G., Crepaz N., Senterfitt J. W., Janssen R. S. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes 2005; 39: 446–453
   PubMed Web of Science ®Google Scholar
• Marx R., Aral S. O., Rolfs R. T. S. C. E., Kahn J. G. Crack, sex, and STD. Sexaully Transmitted Diseases 1991; 8: 92–101
   Google Scholar
• Maslow C. B., Friedman S. R., Perlis T. E., Rockwell R., Des Jarlais D. C. Chagnes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990–1999. American Journal of Public Health 2002; 92: 382–384
   PubMed Web of Science ®Google Scholar
• Masson C. L., Sorensen J. L., Phibbs C. S., Okin R. L. Predictors of medical service utilization among individuals with co-occuring HIV infection and substance abuse disorders. AIDS Care 2004; 16: 744–755
   PubMed Web of Science ®Google Scholar
• McArdle P., Wiegersma A., Gilvarry E. European adolescent substance use: the roles of family, structure fucntion, and gender. Addiction 2002; 97: 329–336
   PubMed Web of Science ®Google Scholar
• McCurdy S. A., Williams M. L., Ross M. W., Kilonzo G. P., Leshabari M. T. A theme issue by, for, and about Africa: new injecting practice increases HIV risk among drug users in Tanzania. Bristish Medical Journal 2005; 331: 778
   PubMedGoogle Scholar
• Metzger D. S., Navaline H. Human immunodeficiency virus prevention and the potential for drug abuse treatment. Clinical Infectious Diseases 2003; 37: S451–S456
   PubMed Web of Science ®Google Scholar
• Mize S. J. S., Robinson B. E., Bockting W. O., Scheltema K. E. Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care 2002; 14: 163–180
   PubMed Web of Science ®Google Scholar
• Molitor F., Ruiz J. D., Flynn N., Mikanda J. N., Sun R. K., Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug & Alcohol Abuse 1999; 25: 475–493
   PubMed Web of Science ®Google Scholar
• Needle R. H., Burrows D., Friedman S. R., Dorabjee J., Touze G., Badrieva L. Effectiveness of community-based outreach in preventing HIV AIDS among injecting drug users. International Journal of Drug Policy 2005; 16S: S45–S57
   Google Scholar
• Needle R. H., Trotter R. T., Singer M., Bates C., Page B., Metzger D. Rapid assessment of the HIV AIDS crisis in racial and ethnic minority communities: an approach for timely community interventions. American Journal of Public Health 2003; 93: 970–979
   PubMed Web of Science ®Google Scholar
• O’Leary A., Martins P. Structural factors affecting women's HIV risk: a life-course example. AIDS 2000; 14: S68–S72
   PubMed Web of Science ®Google Scholar
• Odutolu O. Convergence of behavior change models for AIDS risk reduction in sub-Saharan Africa. International Journal of Health Planning and Management 2005; 20: 239–252
   PubMed Web of Science ®Google Scholar
• Ompad D. C., Ikeda R. M., Shah N., Fuller C. M., Bailey S., Morse E. Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health 2005; 95: 703–709
   PubMed Web of Science ®Google Scholar
• Palepu A., Raj A., Horton N. J., Tibbetts N., Meli S., Samet J. H. Subtsance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. Journal of Substance Abuse Treatment 2005; 28: 3–9
   PubMed Web of Science ®Google Scholar
• Panda S., Chatterjee A., Battacharya S. K., Manna B., Singh P. N., Sarkar S. Transmission of HIV from injecting drug users to their wives in India. International Journal of STD and AIDS 2000; 7: 468–473
   Google Scholar
• Parish W. L., Laumann E. O., Cohen M. S. Population-based study of chlamydia infection in China: a hidden epidemic. Journal of the American Medical Association 2003; 289: 1265–1273
   PubMed Web of Science ®Google Scholar
• Parker R. The global HIV AIDS pandemic, structural inequalities, and the politics of international health. American Journal of Public Health 2002; 92: 343–346
   PubMed Web of Science ®Google Scholar
• Parker R., Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Social Science and Medicine 2003; 57: 13–24
   PubMed Web of Science ®Google Scholar
• Paruk Z., Petersen I., Bhana A., Bell C., McKay M. Containment and contagion: how to strengthen families to support youth HIV prevention in South Africa. African Journal of AIDS Research 2005; 4: 57–63
   PubMedGoogle Scholar
• Pinkerton S. D., Holtgrave D. R., DiFranceisco W. J., Semaan S., Coyle S. L., Johnson-Masotti A. P. Cost-threshold analyses of the national AIDS demonstration research HIV prevention interventions. AIDS 2000; 14: 1257–1268
   PubMed Web of Science ®Google Scholar
• Plitt S. S., Garfein R. S., Gaydos C. A., Strathdee S. A., Sherman S. G., Taha T. E. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sexually Transmitted Diseases 2005; 32: 446–453
   PubMed Web of Science ®Google Scholar
• Plitt S. S., Sherman S. G., Strathdee S. A., Taha T. E. Herpes simplex virus 2 and syphilis among drug users in Baltimore Maryland. Sexually Transmitted Infections 2005; 81: 248–253
   PubMed Web of Science ®Google Scholar
• Power R., Nozhkina N., Kanarsky I. Injecting drug users’ experiences of targeted harm reduction in the Russian Federation. Drug and Alcohol Dependence 2005; 24: 69–77
   Google Scholar
• Prochaska J. O., Velicer W. F. The transtheoretical model of health behavior change. American Journal of Health Promotion 1997; 12: 38
   PubMed Web of Science ®Google Scholar
• Pugatch D. L., Levesque B. G., Lally M. A., Reinert S. E., Filippone W. J., Combes C. M. HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment. J AIDS 2001; 27: 135–142
   PubMed Web of Science ®Google Scholar
• Purcell D. W., Metsch L. R., Latka M., Santibanez S., Gomez C. A., Eldred L. Interventions for seropositive injectors -research and evaluation (INSPIRE): an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes 2004; 37: S118
   Web of Science ®Google Scholar
• Quan V. M., Steketee R. W., Valleroy L., Weinstock H., Karon J., Janssen R. HIV incidence in the United States 1978–1999. J AIDS 2002; 31: 188–201
   PubMed Web of Science ®Google Scholar
• Rhodes T., Singer M., Bourgois P., Friedman S. R., Strathdee S. A. The social structural production of HIV risk among injection drug users. Social Science and Medicine 2005; 61: 1026–1044
   PubMed Web of Science ®Google Scholar
• Robertson J. R., Bucknall A. B. V., Welsby P. D., Roberts J. J. K., Inglis J. M., Peutherer J. F. Epidemics of AIDS related virus (HTLV-III LAV) infection among intravenous drug users. Bristish Medical Journal 1986; 292: 527–529
   PubMed Web of Science ®Google Scholar
• Ross M. W., Hwang L. Y., Leonard L., Teng M., Duncan L. Sexual behavior, STDs and drug use in a crack house population. International Journal of STD and AIDS 1999; 10: 224–230
   PubMed Web of Science ®Google Scholar
• Ross M. W., Hwang L. Y., Zack C., Bull L., Williams M. L. Sexual risk behaviors and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STD & AIDS 2002; 13: 769–774
   PubMed Web of Science ®Google Scholar
• Rotheram-Borus M. J., Flannery D., Rice E., Lester P. Families living with HIV. AIDS Care 2005; 17: 978–987
   PubMed Web of Science ®Google Scholar
• Rusch M. L., Farzadegan H., Tarwater P. M., Safaeian M., Valhov D., Strathdee S. A. Sexual risk behavior among injection drug users before widespeard availability of highly active antiretroviral therapy. AIDS and Behavior 2005; 18: 1–11
   Google Scholar
• Ryan C., Semaan S., Astrat L.. The interface between sex and drugs: implications for prevention of a generalized epidemic in Vietnam. Presented at the Vietnam MOH and CDC workshop on preventing HIV transmission in injection drug users and other vulnerable populations: a review of evidence-based findings and best practices, Hanoi, Vietnam, 2003
   Google Scholar
• Saidel T., Des Jarlais D. C., Peerapatonapokin W. Potential impact of HIV among injection drug users on heterosexual transmission in Asian settings: scenarios from the Asian epidemic model. Journal of Drug Policy 2003; 14: 63–74
   Google Scholar
• Sangani P., Rutherford G., Wilkinson D. Population-based interventions for reducing sexually transmitted infections, including HIV infection [review]. Cochrane Database, 2004; CDC001220
   Google Scholar
• Semaan S., Des Jarlais D., Malow R. Sexually transmitted diseases among illicit drug users in the United States: the need for interventions. Behavioral Interventions for Prevention and Control of Sexually Transmitted Diseases, S. O. Aral, J. Douglas. Spinger-SBM, New York 2006
   Google Scholar
• Semaan S., Des Jarlais D. C., Sogolow E., Johnson W., Hedges L., Ramirez G. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndrome 2002; 30: S73–S93
   PubMed Web of Science ®Google Scholar
• Semaan S., Lauby J., Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Review 2002; 4: 213–223
   PubMedGoogle Scholar
• Semple S. J., Grant I., Patterson T. L. Negative self-perceptions and sexual risk behavior among heterosexual methamphetamine users. Substance Use & Misuse 2005; 40: 1797–1810
   PubMed Web of Science ®Google Scholar
• Semple S. J., Grant I., Patterson T. L. Female methamphetamine users: social characteristics and sexual risk behavior. 2004a; 40: 50
   Google Scholar
• Semple S. J., Patterson T. L., Grant I. Determinants of condom use stage of change among heterosexually-identified methamphetamine users. AIDS and Behavior 2004b; 8: 391–400
   PubMed Web of Science ®Google Scholar
• Semple S. J., Patterson T. L., Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addictive Behaviors 2004c; 29: 807–810
   PubMed Web of Science ®Google Scholar
• Shakarishvili A., Dubovskaya L. K., Zohrabyan L. S., St. Lawrence J. S., Aral S. O., Dugasheva L. G. Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation. Lancet 2005; 366: 57–60
   PubMed Web of Science ®Google Scholar
• Sherman S. G., German D., Cheng Y., Marks M., Bailey-Kloche M. The evaluation of the Jewel project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care 2006; 18: 1–11
   PubMed Web of Science ®Google Scholar
• Siegfried N., Clarke M., Volmink J. Randomized controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. British Medical Journal 2005; 331: 742
   PubMed Web of Science ®Google Scholar
• Smith Fawzi M. C., Lambert W., Singler J. M., Koenig S. P., Leandre F., Nevil P. Prevalence and risk factors of sexually transmitted diseases in rural Haiti: implications for policy and programming in resource-poor settings. International Journal of STD and AIDS 2003; 14: 848–853
   PubMed Web of Science ®Google Scholar
• Sogolow E., Kay L., Doll L. et al. Strengthening HIV prevention: Application of a research to practice framework. AIDS Education and Prevention 2000; 12: 21–32
   PubMed Web of Science ®Google Scholar
• Solomon J., Card J. J., Malow R. M. Adapting efficacious interventions: advancing translational research in HIV prevention. Evaluation and the Health Professions. 2006
   PubMed Web of Science ®Google Scholar
• Sterk C. E., Theall K. P., Elifson K. W. Health care utilization among drug-using and non-drug-using women. Journal of Urban Health 2002; 79: 586–599
   PubMed Web of Science ®Google Scholar
• Sterk C. E., Theall K. P., Elifson K. W. Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Education and Prevention 2003; 15: 15–32
   PubMed Web of Science ®Google Scholar
• Stimson G., Des Jarlais D. C., Ball A. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. University College of London Press, London 1998
   Google Scholar
• Stimson G. V. H. M., Rhodes T., Bastos F., Saidel T. Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions. International Journal of Drug Policy. 2005
   Web of Science ®Google Scholar
• Strathdee S., Galai N., Safaeian M. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine 2001; 161: 1281–1288
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Palepu A., Cornelisse P. G. A., Yip B. V., O'Shaughnessy M. V., Montaner J. S. G. Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association 1998; 280: 547–549
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Sherman S. G. The role of sexual transmission of HIV injection and non-injection drug users. Journal of Urban Health 2003; 80: iii7–iii14
   PubMed Web of Science ®Google Scholar
• Sumartojo E., Doll L., Holtgrave D., Gayle H., Merson M. Enriching the mix: incorporating the structural factors into HIV prevention. AIDS 2000; 14: S1–S2
   PubMed Web of Science ®Google Scholar
• Thompson J. C., Kao T. C., Thomas R. J. The relationship between alcohol use and risk-taking sexual behaviors in a large behavioral study. Preventive Medicine 2005; 41: 247–252
   PubMed Web of Science ®Google Scholar
• Tran T. N., Detels R., Long H. T., Lan H. P. Drug use among female sex workers in Hanoi, Vietnam. Addiction 2005; 100: 619–625
   PubMed Web of Science ®Google Scholar
• Tuli K., Sansom S., Purcell D. W., Metsch L. R., Latkin C. A., Gourevitch M. N. Economic evaluation of an HIV prevention intervention for seropositive injection drug users. Journal of Public Health Management & Practice 11. 2005
   Google Scholar
• UNAIDS. UNAIDS 2004 Report on the Global AIDS Epidemic. UNAIDS, Bangkok 2004
   Google Scholar
• Uuskula A., Nygard J. F., Kibur-Nygard M. Syphilis as a social disease: experience from the post-communist transition period in Estonia. International Journal of STD & AIDS 2004; 15: 662–668
   PubMed Web of Science ®Google Scholar
• van Empelen P., Kok G., van Kesteren N. M. C., ven den Borne B., Bos A. E. R., Schaalma H. P. Effective methods to change sex-risk among drug users: a review of psychosocial interventions. Social Science and Medicine 2003; 57: 1593–1608
   PubMed Web of Science ®Google Scholar
• Vlahov D., Safaien M., Lai S., Strathdee S. A., Johnson L., Sterling T. Sexual and drug risk-related beahviours after initiating highly active antiretroviral therapy among injection drug users. AIDS 2001; 15: 2311–2316
   PubMed Web of Science ®Google Scholar
• Ware N. C., Wyatt M. A., Tugenberg T. Adherence stereotyping and unequal HIV treatment for active users of illegal drugs. Social Science & Medicine 2005; 61: 565–576
   PubMed Web of Science ®Google Scholar
• Wendell D. A., Cohen D. A., Le Sage D., Farley T. A. Street outreach for HIV prevention: effectiveness of a state-wide programme. International Journal of STD and AIDS 2003; 14: 334–340
   PubMed Web of Science ®Google Scholar
• White R. G., Orroth K. K., Kornromp E. L., Bakker R., Wambura M., Sewankambo N. K. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV sexually transmitted disease intervention trials? A modeling study. Journal of Acquired Immune Deficiency Syndrome 2004; 37: 1500–1513
   PubMed Web of Science ®Google Scholar
• Williams M. L., Atkinson J., Klovdahl A., Ross M. W., Timpson S. Spatial bridging in a network of drug-using male sex workers. Spatial bridging in a network of drug-using male sex workers 2005; 1: i35–i42
   Google Scholar
• Wodak A., Cooney A. Effectiveness of sterile needle and syringe programmes. International Journal of Drug Policy 2005; 16S: S31–S44
   Web of Science ®Google Scholar
• Wohl A. R., Johnson D. F., Lu S., Jordan W., Beall G., Currier J. HIV risk behaviors among African American men in Los Angeles County who self identify as heterosexual. Journal of Acquired Immune Deficiency Syndrome 2002; 31: 354–360
   PubMed Web of Science ®Google Scholar
• World Health Organization. Management of Substance Abuse: WHO Drug Injection Study. World Health Organization, GenevaSwitzerland 2003
   Google Scholar
• Young R. M., Case P., Friedman S. R. Exploring an HIV paradox: an ethnography of sexual minority women injectors. Journal of Lesbian Studies 2006; (in press)
   Google Scholar
• Young R. M., Friedman S. R., Case P., Asencio M. W., Clatts M. Women injection drug users who have sex with women exhibit increased HIV infection and risk behaviors. Journal of Drug Issues 2000; 30: 499–524
   Web of Science ®Google Scholar